Lipid core-chitosan shell hybrid nanoparticles for enhanced oral bioavailability of sorafenib.
Sahar NU, Gul M, Choi HI, Ryu JS, Noh HY, Vo DK, Nguyen TH, Ansari MM, Kim W, Maeng HJ, Zeb A, Kim JK.
Sahar NU, et al. Among authors: kim jk.
Int J Biol Macromol. 2025 Jan 21:140030. doi: 10.1016/j.ijbiomac.2025.140030. Online ahead of print.
Int J Biol Macromol. 2025.
PMID: 39848373